MMM 3M CO

NYSE Surgical & Medical Instruments & Apparatus DE CIK: 0000066740
AI RATING
HOLD
72% Confidence

Investment Thesis

3M exhibits strong operational profitability (23.2% operating margin, 20% ROE) but faces significant headwinds including zero revenue growth, declining EPS (-20.5%), and elevated financial leverage (3.34x D/E) that constrains strategic flexibility. The company generates positive free cash flow ($349M) with manageable interest coverage (13.2x), but weak asset utilization (1.8% ROA) and declining cash conversion suggest efficiency challenges.

Strengths

  • + Strong operating margin of 23.2% demonstrates pricing power and operational efficiency in mature markets
  • + Excellent return on equity of 20% and solid interest coverage ratio of 13.2x indicate current debt is serviceable
  • + Positive free cash flow generation of $349M provides cushion for dividend and debt servicing despite leverage

Risks

  • ! Revenue stagnation at 0% YoY growth in latest period signals market maturity and competitive pressure with no organic expansion
  • ! Excessive financial leverage at 3.34x debt-to-equity limits strategic flexibility and increases refinancing risk in higher rate environment
  • ! Declining diluted EPS (-20.5% YoY) despite flat net income and weak FCF margin (5.8%) suggest deteriorating capital efficiency and shareholder value creation

Key Metrics to Watch

Financial Metrics

Revenue
6.0B
Net Income
653.0M
EPS (Diluted)
$1.23
Free Cash Flow
349.0M
Total Assets
35.4B
Cash
3.7B

Profitability Ratios

Gross Margin N/A
Operating Margin 23.2%
Net Margin 10.8%
ROE 20.0%
ROA 1.8%
FCF Margin 5.8%

Balance Sheet & Liquidity

Current Ratio
1.59x
Quick Ratio
1.19x
Debt/Equity
3.34x
Debt/Assets
90.7%
Interest Coverage
13.18x
Long-term Debt
10.9B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-29T13:27:05.275011 | Data as of: 2026-03-31 | Powered by Claude AI